Trandolapril - ≥98%, high purity , Angiotensin-converting enzyme inhibitor, CAS No.87679-37-6, Angiotensin-converting enzyme inhibitor

Item Number

T276217

• Synonyms: D00383 | SR-02000000917 | Tox21_113152 | 1H-Indole-2-carboxylic acid, 1-((2S)-2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S,3aR,7aS)- | BDBM50369775 | Gopten | STK802586 | Trandolaprilum (Latin) | 1-(2-((1-(ethoxycarbonyl)-3-phe
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Potent angiotensin-converting enzyme (ACE) inhibitor (IC 50 = 2.5 nM). Prevents the conversion of angiotensin I into angiotensin II. Potent vasoconstrictor.
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Angiotensin-converting enzyme inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Product description：

Trandolapril (RU44570) is a nonsulfhydryl prodrug that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI).